Delivery Order SPE2DB22D1202-SPE2DB24FVMQ1
Award Date
9/3/24
Potential Completion Date
9/4/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,091.04 firm fixed-price delivery order is for the supply of insulin glargine-yfgn U100 pens. The contract has an ultimate completion date of November 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,841.00, is for the delivery of insulin glargine-yfgn U100 pens over a period ending on December 30, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,788.60 firm fixed-price delivery order is for the supply of insulin glargine-yfgn U100 pens, with a completion date of December 24, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award is for the delivery of insulin glargine-yfgn U100 pens, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor on this firm fixed price delivery order contract is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a ceiling value of $2,172.90 and a completion date of March 21, 2024. No...
This federal contract award, valued at $4,091.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of insulin glargine-yfgn U100 pens, a critical diabetes management medication, with a completion date of December 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,683.31, is for the delivery of insulin glargine-yfgn U100 pens. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 29, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,244.19 Firm Fixed Price Delivery Order covers the supply of Insulin Glargine-yfgn U100 Pens with an ultimate completion date of December 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,549.94, is for the delivery of Insulin Glargine-yfgn U100 Pens. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of May 10, 2024. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,582.59 firm fixed-price delivery order is for the supply of INSULIN GLARGINE-YFGN U100 PEN 3ML, a type of insulin medication. The contract has an ultimate completion date of January 21, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of Insulin Glargine-yfgn U100 Pen 3ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $3,954.24. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 13, 2024. This award is not...